Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 29, 2020 - Issue 3
Submit an article Journal homepage
492
Views
9
CrossRef citations to date
0
Altmetric
Review

Investigational drugs to treat hemophilia

Massimo Franchinia Italian National Blood Centre, National Institute of Health, Rome, Italy;b Department of Hematology and Transfusion Medicine, Carlo Poma Hospital, Mantua, ItalyCorrespondence[email protected]
View further author information
,
Giuseppe Maranoa Italian National Blood Centre, National Institute of Health, Rome, ItalyView further author information
,
Ilaria Patia Italian National Blood Centre, National Institute of Health, Rome, ItalyView further author information
,
Eva Veropalumboa Italian National Blood Centre, National Institute of Health, Rome, ItalyView further author information
,
Stefania Vaglioa Italian National Blood Centre, National Institute of Health, Rome, ItalyView further author information
,
Simonetta Pupellaa Italian National Blood Centre, National Institute of Health, Rome, ItalyORCID Iconhttps://orcid.org/0000-0002-5356-6003View further author information
ORCID Icon,
Francesca Masielloa Italian National Blood Centre, National Institute of Health, Rome, ItalyView further author information
,
Mario Cruciania Italian National Blood Centre, National Institute of Health, Rome, Italy;c Infection Control Committee and Antibiotic Stewardship Programme, AULSS9 Scaligera, Verona, ItalyView further author information
,
Carlo Mengolia Italian National Blood Centre, National Institute of Health, Rome, ItalyView further author information
&
Giancarlo Maria Liumbrunoa Italian National Blood Centre, National Institute of Health, Rome, ItalyView further author information
 show all
Pages 295-301 | Received 24 Sep 2019, Accepted 25 Jan 2020, Published online: 03 Feb 2020

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Kanjaksha Ghosh & Kinjalka Ghosh. (2022) Monoclonal antibodies used for the management of hemataological disorders. Expert Review of Hematology 15:5, pages 443-455.
Read now
Massimo Franchini, Michele Schiavulli & Giancarlo Maria Liumbruno. (2021) Hemostatic therapy as a management strategy for acquired hemophilia: what does the future hold?. Expert Review of Hematology 14:3, pages 263-270.
Read now
Massimo Franchini, Giuseppe Marano, Mario Cruciani, Carlo Mengoli, Ilaria Pati, Francesca Masiello, Eva Veropalumbo, Simonetta Pupella, Stefania Vaglio & Giancarlo Maria Liumbruno. (2020) Advances in managing rare acquired bleeding disorders. Expert Review of Hematology 13:6, pages 599-606.
Read now

Articles from other publishers (6)

Jane PF Bai, Jie Wang, Yifei Zhang, Lingshan Wang & Xiling Jiang. (2023) Quantitative Systems Pharmacology for Rare Disease Drug Development. Journal of Pharmaceutical Sciences 112:9, pages 2313-2320.
Crossref
Ana Marco-Rico. (2023) Hematological treatment and prophylaxis in patients with and without inhibitors. Blood Coagulation & Fibrinolysis 34:S1, pages S9-S11.
Crossref
Romeo Gabriel Mihaila. (2023) From a bispecific monoclonal antibody to gene therapy: A new era in the treatment of hemophilia A. Biomedical Papers 167:1, pages 1-8.
Crossref
Junzheng Wu, Hang Zhang, Tong Lian, Yaling Ding, Chunlei Song, Dekuan Li, Liheng Wu, Tao Lei & Hong Liang. (2023) Biological activity of a new recombinant human coagulation factor VIII and its efficacy in a small animal model. Biochemical and Biophysical Research Communications 640, pages 80-87.
Crossref
Karen Beny, Amélie Dubromel, Benjamin du Sartz de Vigneulles, Valérie Gay, Florence Carrouel, Claude Negrier & Claude Dussart. (2022) Multiple criteria decision analysis for therapeutic innovations in a hemophilia care center: A pilot study of the organizational impact of innovation in hemophilia care management. PLOS ONE 17:9, pages e0273775.
Crossref
Kanjaksha GhoshKinjalka Ghosh. (2021) Monoclonal antibodies used for management of hematological disorders. Journal of Hematology and Allied Sciences 1, pages 12-21.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.